HOOK Stock Summary and Trading Ideas (Hookipa Pharma | NASDAQ:HOOK)

HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.

Hookipa Pharma trades on the NASDAQ stock market under the symbol HOOK.

As of April 26, 2024, HOOK stock price climbed to $0.90 with 2,633,524 million shares trading.

HOOK has a beta of 1.30, meaning it tends to be more sensitive to market movements. HOOK has a correlation of 0.03 to the broad based SPY ETF.

HOOK has a market cap of $89.06 million. This is considered a Micro Cap stock.

Last quarter Hookipa Pharma reported $7 million in Revenue and -$.11 earnings per share. This beat revenue expectation by $3 million and exceeded earnings estimates by $.08.

In the last 3 years, HOOK stock traded as high as $20.00 and as low as $.41.

The top ETF exchange traded funds that HOOK belongs to (by Net Assets): VTI, VXF, IWC.

HOOK stock has underperformed the market in the last year with a return of -5.4%, while SPY returned +27.1%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in HOOK shares. However, HOOK has outperformed the market in the last 3 month and 2 week periods, returning +26.8% and +11.8%, while SPY returned +4.7% and -1.7%, respectively. This indicates HOOK has been having a stronger performance recently.

HOOK support price is $.75 and resistance is $.86 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HOOK stock will trade within this expected range on the day.